Holen Sie sich die Stockscreener-App
15.40
1.35%
-0.21
Handel nachbörslich:
15.69
0.29
+1.88%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$15.61
Offen:
$15.72
24-Stunden-Volumen:
873.36K
Relative Volume:
0.72
Marktkapitalisierung:
$708.59M
Einnahmen:
$203.27M
Nettoeinkommen (Verlust:
$-4.66M
KGV:
-154.00
EPS:
-0.1
Netto-Cashflow:
$3.47M
1W Leistung:
-5.06%
1M Leistung:
+22.71%
6M Leistung:
-17.29%
1J Leistung:
+17.92%
1-Tages-Spanne:
$15.32
$15.82
1-Wochen-Bereich:
$15.24
$16.47
52-Wochen-Spanne:
$9.215
$21.00
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Vergleichen Sie AXGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
15.40 | 722.86M | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Top chart patterns to watch in Axogen Inc.Portfolio Growth Summary & Low Risk Growth Stock Ideas - Newser
Real time scanner hits for Axogen Inc. explainedBreakout Watch & Step-by-Step Swing Trade Plans - Newser
Is Axogen Inc. still worth holding after the dipWeekly Trade Report & Long-Term Growth Stock Strategies - Newser
Key metrics from Axogen Inc.’s quarterly data2025 Volatility Report & Fast Entry and Exit Trade Plans - Newser
Can Axogen Inc. hit a new high this monthWeekly Loss Report & Reliable Price Breakout Alerts - Newser
Statistical indicators supporting Axogen Inc.’s strength2025 Pullback Review & Advanced Technical Analysis Signals - Newser
What high frequency data says about Axogen Inc.2025 Trade Ideas & Real-Time Stock Movement Alerts - Newser
Can technical indicators confirm Axogen Inc.’s reversalPortfolio Return Summary & Safe Capital Growth Stock Tips - Newser
Developing predictive dashboards with Axogen Inc. data2025 Price Action Summary & Consistent Profit Focused Trading Strategies - Newser
Is Axogen Inc. a candidate for recovery playWeekly Profit Recap & Capital Efficiency Focused Ideas - Newser
Can Axogen Inc. grow without external fundingJuly 2025 Levels & Growth Focused Stock Reports - khodrobank.com
Sector ETF performance correlation with Axogen Inc.Portfolio Return Report & Smart Allocation Stock Tips - Newser
Signal strength of Axogen Inc. stock in tech scannersShare Buyback & High Accuracy Swing Trade Signals - Newser
Technical signs of recovery in Axogen Inc.2025 Dividend Review & Daily Chart Pattern Signal Reports - Newser
What data driven models say about Axogen Inc.’s futureTrade Exit Summary & Weekly Breakout Watchlists - Newser
Price momentum metrics for Axogen Inc. explainedTrade Ideas & Fast Exit and Entry Strategy Plans - Newser
Analyzing Axogen Inc. with risk reward ratio chartsEarnings Risk Summary & Weekly Top Gainers Alerts - Newser
Axogen Inc. Stock Approaches Key Moving AveragePortfolio Performance Summary & Fast Moving Market Watchlists - beatles.ru
What does recent volatility data suggest for Axogen IncStop Loss & Long-Term Growth Stock Strategies - Newser
Published on: 2025-08-31 19:47:00 - Newser
Why Axogen Inc. stock attracts strong analyst attentionProduct Launch & Reliable Price Action Trade Plans - Newser
Axogen Inc.’s volatility index tracking explained2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Building trade automation scripts for Axogen Inc.Bond Market & Risk Controlled Swing Trade Alerts - Newser
What does recent volatility data suggest for Axogen Inc.July 2025 PreEarnings & AI Enhanced Trade Execution Alerts - Newser
How high can Axogen Inc. stock goQuarterly Risk Review & Daily Risk Controlled Trade Plans - Newser
Will Axogen Inc. bounce back from current supportQuarterly Portfolio Review & Consistent Growth Equity Picks - Newser
Institutional Ownership and Strategic Influence in Axogen, Inc. (NASDAQ:AXGN): A Double-Edged Sword for Shareholders - AInvest
Axogen's Ownership Structure: Institutional Dominance and Insider Sales - AInvest
With 88% ownership of the shares, Axogen, Inc. (NASDAQ:AXGN) is heavily dominated by institutional owners - Yahoo Finance
What MACD signals say about Axogen Inc.Weekly Earnings Recap & Verified Momentum Stock Alerts - Newser
Using data tools to time your Axogen Inc. exitJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
AxoGen: FDA extends PDUFA date for BLA for Avance Nerve Graft to December 5 - MSN
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Axogen Inc-Aktie (AXGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Levine Alan M | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
36,743 |
| Wendell Amy McBride | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
93,826 |
| Burke William P. Mr. | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
24,484 |
| NEELS GUIDO J | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
86,743 |
| JOHNSON JOHN | Director |
Jun 09 '25 |
Sale |
10.61 |
4,073 |
43,215 |
24,943 |
| TYNDALL JOSEPH A. | Director |
Jun 10 '25 |
Option Exercise |
6.56 |
11,586 |
75,952 |
26,931 |
| TYNDALL JOSEPH A. | Director |
Jun 10 '25 |
Sale |
10.72 |
26,931 |
288,700 |
0 |
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):